Edition:
United States

People: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

50.90USD
18 Aug 2017
Change (% chg)

$-0.02 (-0.04%)
Prev Close
$50.92
Open
$50.88
Day's High
$51.32
Day's Low
$50.42
Volume
701,043
Avg. Vol
804,970
52-wk High
$63.40
52-wk Low
$41.93

Bloom, Floyd 

Dr. Floyd E. Bloom M.D. is Independent Director of the Company. Dr. Bloom was a founder of Alkermes, Inc. and has been active in neuropharmacology for more than 35 years, holding positions at Yale University, the National Institute of Mental Health, The Salk Institute, and The Scripps Research Institute. From 1983 to February 2005, Dr. Bloom was the Chairman of the Neuropharmacology Department at The Scripps Research Institute and is now Professor Emeritus. Dr. Bloom served as Editor-in-Chief of Science from 1995 to May 2000. He is a member of the National Academy of Sciences, the Royal Swedish Academy of Science and the American Philosophical Society. He is an Emeritus Trustee for the Board of Trustees at Washington University in St. Louis. Dr. Bloom is a director of AgeneBio, Inc. a privately held biopharmaceutical company. Dr. Bloom also serves on the Scientific Advisory Boards of aTyr Pharma, a privately held pharmaceutical company, RiverVest, a private venture partnership focusing on life sciences, and Interpreta Inc., a privately held analytics service company, and as chairman of the Scientific Board for ModGene Pharma LLC, a privately held research and development company. Dr. Bloom served as a member of the board of directors of Elan from 2007 to 2009.

Basic Compensation

Total Annual Compensation, USD 85,500
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 423,986
Fiscal Year Total, USD 509,486

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Pops

9,647,420

Shane Cooke

4,144,870

James Frates

2,678,060

Kathryn Biberstein

3,430,420

Elliot Ehrich

3,452,210

Iain Brown

--
As Of  30 Dec 2016